Quick Answer
Clearside Biomedical, Inc. reported Total Assets of $25.13 million for fiscal year 2024.
Clearside Biomedical, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2024 | $25.13M | -26.1% |
| 2023 | $34.02M | -33.7% |
| 2022 | $51.30M | +19.6% |
| 2021 | $42.90M | +122.0% |
| 2020 | $19.32M | -27.8% |
| 2019 | $26.78M | -39.3% |
| 2018 | $44.12M | +9.0% |
| 2017 | $40.49M | -52.3% |
| 2016 | $84.81M | +302.8% |
| 2015 | $21.05M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $11.64M | -60.1% | -24.1% |
| June 30, 2025 | $15.33M | -54.8% | -22.0% |
| March 31, 2025 | $19.67M | -51.0% | -21.7% |
| December 31, 2024 | $25.13M | -26.1% | -13.8% |
| September 30, 2024 | $29.16M | -15.3% | -14.1% |
| June 30, 2024 | $33.93M | -13.4% | -15.5% |
| March 31, 2024 | $40.14M | -10.2% | +18.0% |
| December 31, 2023 | $34.02M | -33.7% | -1.2% |
- Clearside Biomedical, Inc. showed a decrease of -26.1% in Total Assets compared to the prior fiscal year.
- Over the 2015–2024 period, Clearside Biomedical, Inc.’s total assets has grown by 19.3% (from $21.05 million to $25.13 million).
- The most recent figure is from Clearside Biomedical, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 27, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: